Mustafa Berktaş

Mustafa Berktaş

Auto-generated profile, based on publicly available information

Mustafa Berktaş

İzmir Bakırçay Üniversitesi

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2017 in Japanese Journal of Infectious Diseases
Verified
Journal Article
Open access
YBYasemin Bayram
Yasemin Bayram
MPMehmet Parlak
Mehmet Parlak
AÖAyşe Özkaçmaz
Ayşe Özkaçmaz
AÇAytekin ÇIkman
Aytekin ÇIkman
HGHÜSeyin GÜDÜCÜOǧlu
HÜSeyin GÜDÜCÜOǧlu
CACenk A. Andac
Cenk A. Andac
Crimean-Congo hemorrhagic fever (CCHF) is an endemic tick-borne viral disease that affects both animals and humans. This study aims to determine the seroprevalence of CCHF in Turkey's Van province using analysis of blood samples obtained from people living in the region. Blood specimens were taken from healthy subjects living in Van province and some of the surrounding villages between January and July 2012. Blood samples were initially tested using a CCHF virus (CCHFV) IgM IgG kit for anti-CCHFV IgG, followed by anti-CCHFV IgM determination of any IgG positive blood samples. IgM-positive specimens were re-confirmed using real-time polymerase chain reaction (qPCR). One hundred and 7 men and 261 women were included in the study. Fifty-three blood specimens (14.4%) were anti-CCHFV IgG positive, and 2 of these were anti-CCHFV IgM positive. Two blood samples with anti-CCHFV IgM seropositivity tested negative using qPCR, indicating chronic infections. Locality, sex, and a history of tick bites did not significantly affect anti-CCHFV IgG seropositivity. Although the incidence of anti-CCHFV IgG in blood specimens was 14.4%, no deaths have yet been reported in Turkey's Van province. It is imperative that clinical CCHFV tests be implemented for people at high risk of developing CCHFV-related complications.

12 March 2024 in Yuksekogretim Dergisi
Verified
Journal Article
Open access
PDF file
BKBayram KÖSE
Bayram KÖSE
SASerkan Ansay
Serkan Ansay
TATarkan Akderya
Tarkan Akderya
GTGülbahar Tabakoğlu
Gülbahar Tabakoğlu
KHKadir Hızıroğlu
Kadir Hızıroğlu
MBMustafa Berktaş
Mustafa Berktaş
Sürekli gelişen teknoloji, nüfus artışı ve bunlara paralel olarak çeşitlenen tüketim alışkanlıkları karşılanırken ekolojik dengenin bir parçası olan tüm canlıların hakları gözetilmeli, kaynaklar tüm canlılar tarafından adil kullanılmalıdır. Birleşmiş Milletler'in oluşturduğu iklim değişikliği mücadelesi ve Avrupa Yeşil Mutabakatı'nın uygulanmasının hem insan doğası hem de ekolojik çevre ile uyumlu olması önemlidir. Bu çalışmada özgür ve bilimsel bir temelde faaliyet gösteren üniversitelerin yeşil sertifikasyon süreçleri incelenmiş ve sürdürülebilir kalkınma hedefleriyle ilişkisi ortaya konulmuştur. Ayrıca Türkiye'deki üniversitelerin Yeşil Sertifikalandırma çalışmaları genel bir çerçevede incelenmiştir. Sonuç olarak, Türkiye'deki üniversitelerin son yıllarda sürdürülebilirlik çalışmalarına öncelik verdiği, farkındalık ve tanıtım açısından yeşil sertifika verilen kuruluşlara katılımlarında artış olduğu gözlemlenmiştir.

11 November 2024
Verified
Book
Closed access
MBMustafa Berktas
Mustafa Berktas
AHAbdulkadir Hiziroglu
Abdulkadir Hiziroglu
AEAhmet Emin Erbaycu
Ahmet Emin Erbaycu
Orhan EROrhan ER
Orhan ER
Sezer Bozkus KahyaogluSezer Bozkus Kahyaoglu
Sezer Bozkus Kahyaoglu
Healthcare and medical science are inherently dependent on technological advances and innovations for improved care. In recent times we have witnessed a new drive in implementing these advances and innovations through the use of Artificial Intelligence, in both clinical and non-clinical areas. The set of 2 volumes aims to make available the latest research and applications to all, and to present the current state of clinical and non-clinical applications in the health sector and areas open to development, as well as to provide recommendations to policymakers. This volume covers non-clinical applications. The chapters covered in this book have been written by professionals who are experts in the healthcare sector and have academic experience. <!----> <!----> <!----> <!---->

11 November 2024
Verified
Book Chapter
Closed access
PDF file
MBMustafa Berktas
Mustafa Berktas
AEAhmet Emin Erbaycu
Ahmet Emin Erbaycu
KHKadir Hiziroglu
Kadir Hiziroglu
Orhan EROrhan ER
Orhan ER
Sezer Bozkus KahyaogluSezer Bozkus Kahyaoglu
Sezer Bozkus Kahyaoglu
This chapter provides the general framework for a basic introduction to non-clinical applications of artificial intelligence (AI) in the healthcare industry. All activities related to patient care that are not observable in the disease treatment process can be referred to as non-clinical healthcare activities. The healthcare industry appears as a top priority in almost every subject in both advanced and emerging countries around the world. Therefore, this book is planned with the aim of closely examining and contributing to the dynamics of the healthcare sector, which has such a strategic importance and social impact. In this respect, Volume 1 covers non-clinical applications of AI and, as a next step, Volume 2 will provide information on the impact of AI on clinical implications. In this context, a wide range of topics will be described, from health big data and the characteristics of the health big data production process to key processes related to health service delivery, quality and accreditation. While the health industry is large in scale, it also has a very complex structure in terms of its operations, services and technologies. For this reason, it is one of the sectors expected to internalize and exploit technological advances most quickly. AI, which is contributing to revolutionary innovations in technological development, is spreading widely through intelligent tools with different algorithms based on machine learning and deep learning techniques. While the applications of artificial intelligence have benefits, they also pose challenges. The topics discussed in this book attempt to open the discussion on all aspects of AI with a balanced approach based on the literature. It provides value-added recommendations for public health management that should be considered in the development of health policies needed to improve service standards and quality, especially in the healthcare industry and the healthcare supply chain process. <!----> <!----> <!----> <!---->

1 January 2022 in Journal of Basic and Clinical Health Sciences
Verified
Journal Article
Closed access
MÖM. Burak Öztop
M. Burak Öztop
APAhu Pakdemi̇rli̇
Ahu Pakdemi̇rli̇
DODilek Orbatu
Dilek Orbatu
AEAhmet Emin Erbaycu
Ahmet Emin Erbaycu
SOSENEM Alkan Ozdemir
SENEM Alkan Ozdemir
MBMustafa Berktaş
Mustafa Berktaş
Purpose: New viruses have emerged, causing global damage and mass deaths that can spread to international borders, the latest of which is the new coronavirus (COVID-19). After the Second International Congress on Artificial Intelligence in Health, themed "Artificial Intelligence in Health During COVID-19 Pandemic Process" organized online by Izmir Bakircay University and Izmir Provincial Health Directorate with the contributions of the International Association of Artificial Intelligence in Health, a questionnaire was conducted to evaluate the knowledge of the participants about artificial intelligence applications.Material and Methods: This study aimed to evaluate the interest of the congress participants in this field with the questions which form the questionnaire such as the duration of the interest of the participants in the field of artificial intelligence in health, their publication status, the development of studies on artificial intelligence with the COVID-19 pandemic, demographic structures such as age and gender, and educational level. 130 participants answered the questionnaire consisting of 23 questions. Questionnaire responses were analyzed in a statistical setting.Results: We found that 130 people filled out the questionnaire and the majority of the participants were female, with participation from many organizations, but university staff showed more interest. We have seen that the 30-39 age group is more interested in artificial intelligence than the other age groups, but the majority of the participants do not have academic studies in this field. We found that the technical terms related to artificial intelligence were not well known by the participants, and that the number of participants who tended to this field, especially in the recent year, was high. Another important point was that people working in this field stated that they would definitely follow up if scientific activities continued.Conclusion: We know how important congresses, symposiums, courses and other meetings are, especially for scientist candidates, which will be held to raise awareness about the usage areas of artificial intelligence-based health technologies, to develop new communication and work networks by bringing together different disciplines, to create an agenda and to lay the groundwork for new studies, and we think that there is a need for many repetitive activities in this field and that these activities should be continued.